Myocardial Infarction

BOSTON — In patients with postinfarction ventricular septal defects, percutaneous and surgical treatments reduced mortality rates compared with historical medical therapy data, researchers reported at TCT 2022.

Last week, Healio reported from the European Society of Cardiology Congress. The top five stories in cardiology are on research presented at the meeting.

Among nonsmokers, data showed a link between higher concentrations of air pollution and greater MI incidence in Germany, researchers reported at the European Society of Cardiology Congress.

After STEMI treated with primary PCI, men and women were equally likely to experience any MI, any revascularization or die of any cause during 10 years of follow-up, data from a retrospective analysis show.

Prediction models incorporating both cardiovascular disease and fracture risk factors may be able to predict the risk for major adverse CV events in adults with osteoporosis, according to study data.

Using noninvasive 18F-sodium fluoride PET and coronary CTA to detect “hot” disease in arteries, researchers were able to predict which patients with recent MI would have recurrent coronary events.

In older adults, a polypill containing aspirin, an ACE inhibitor and a statin within 6 months after myocardial infarction lowered the risk for major adverse CV events compared with usual care, according to results of the SECURE trial.

Patients taking antihypertensive medication in the evening experienced no difference in MI, stroke or CV death occurrence compared with patients taking them in the morning, a speaker reported.

A database analysis showed no association between messenger RNA COVID-19 vaccines and risk for acute MI, stroke or pulmonary embolism, but a slight increase in risk for PE and MI after receiving the AstraZeneca or Janssen vaccines.

Targeted cancer therapy had a higher association with risk for major adverse cardiovascular events than cytokine therapy among patients with advanced renal cell carcinoma, according to study results.